European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP ... Sacramento Bee To address the remaining major objection, the CHMP required that CTI provide a literature review of mechanisms of rituximab resistance and analyses that demonstrate the efficacy of Pixuvri in patients with prior rituximab treatment, ... |
